Kyleena

Levonorgestrel, the active ingredient in Kyleena, is a progestin presented as a 19.5 mg intrauterine system (IUS) for intrauterine use. It provides continuous release of hormone to inhibit ovulation, thicken cervical mucus, and alter the endometrium, thereby preventing pregnancy in women of reproductive age.

GNH USA supplies Kyleena as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide under strict quality standards. The company adheres to Good Distribution Practice and supports regulatory compliance for its clients across multiple regions.

Kyleena, a levonorgestrel‑based intrauterine system, is indicated for hormonal contraception.

Contraception: provides highly effective, reversible prevention of pregnancy for up to five years. Hormonal birth control: delivers continuous low‑dose levonorgestrel to suppress ovulation and thicken cervical mucus. Long‑acting reversible contraception (LARC): offers a convenient, single‑procedure method without daily dosing.

Side effects associated with Kyleena may vary in frequency and severity.

Common Side Effects: - Irregular bleeding or spotting - Amenorrhea (absence of periods) - Pelvic or abdominal pain - Headache

Serious or Rare Side Effects: - Uterine perforation during insertion - Ectopic pregnancy if contraception fails - Pelvic inflammatory disease or infection

Prior to insertion and during use, several precautions should be observed.

Screen for pregnancy: confirm the patient is not pregnant before device placement. Assess uterine anatomy: avoid use in known uterine malformations or fibroids that distort the cavity. Check for active infection: postpone insertion if pelvic infection or sexually transmitted disease is present. Counsel on hormonal effects: discuss possible changes in bleeding patterns and other hormone‑related symptoms. Store at room temperature: keep the device in its original packaging, protect from moisture and direct sunlight.

Levonorgestrel released from Kyleena can interact with other medications that affect hormone metabolism.

Major Interactions (Avoid): - Anticonvulsants such as carbamazepine or phenytoin: may markedly reduce contraceptive efficacy. - Rifampin and other strong enzyme inducers: can lower levonorgestrel levels.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline): may slightly decrease hormone effectiveness. - Herbal supplements like St. John’s wort: potential reduction in contraceptive reliability. - Concurrent hormonal therapies (e.g., estrogen‑containing contraceptives): may increase overall hormonal exposure.